SATURDAY, March 8, 2025 (HealthDay News) -- Cardiovascular disease is a general term that refers to many different types of heart problems. Heart disease is the No. 1 cause of death in the United ...

In this article, we review various hypersensitivity reactions to ASA and discuss desensitization protocols to allow ASA therapy in ASA-sensitive cardiovascular patients ... Stevenson et al 15 describe ...

In September, Akeso, a little-known Chinese biotech company founded nearly a decade ago shook up the biotech sector with its new lung cancer drug ... year to develop cardiovascular medication ...

Generic drugs have saved billions of dollars and benefited countless lives by making existing medicines more affordable. But a new study finds these drug copies may not all be created equal. Despite ...

Oban is home to just 8,000 people and at least eight recent confirmed or suspected victims of drug misuse were buried here. The youngest was 26, the oldest was 48. The population of the town is ...

The researchers found that both SGLT2 inhibitors and GLP-1 agonists were associated with a lower risk of major cardiovascular events, but the drug effects varied with the patients’ age.

Since there is only one ongoing study (39), we cannot include the XO selective, uric acid-lowering drug febuxostat. However, febuxostat recently showed to increase the risk of future development of ...

Understand the decisions to approve or deny the sale of drugs and medical devices in Canada. Research whether a submission for a new drug or a new use for an approved drug has been accepted for review ...